BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7482326)

  • 1. [The physicochemical properties of molsidomine preparations and their efficacy in treating IHD and circulatory failure].
    Körner A; Ol'binskaia LI; Sizova ZhM; Morozov IuA
    Ter Arkh; 1995; 67(8):25-7. PubMed ID: 7482326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of molsidomine preparations on the coronary and myocardial reserves of patients with IHD complicated by circulatory failure].
    Ol'binskaia LI; Sizova ZhM; Alekperov EE
    Ter Arkh; 1994; 66(8):30-2. PubMed ID: 7985149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New drug forms of molsidomine, Corvaton-forte and Corvaton-retard, and their antianginal efficacy in stenocardia patients].
    Kukushkin SK; Shamarin VM; Manoshkina EM; Berzak NV; Petrosian KIu
    Ter Arkh; 1996; 68(1):29-30. PubMed ID: 8644025
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effectiveness of digoxin and sidnofarm in the initial stages of chronic circulatory failure].
    Bondarenko IP; Tkachev VA
    Vrach Delo; 1989 Oct; (10):73-5. PubMed ID: 2617991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The evaluation of the antianginal effect of Corvaton-Retard in patients with ischemic heart disease by using paired bicycle ergometry].
    Runovich AA; Verkhozin IA; Kuril'skaia TE; Zuev AV
    Ter Arkh; 1997; 69(9):51-2. PubMed ID: 9411828
    [No Abstract]   [Full Text] [Related]  

  • 6. [Efficacy of corvaton in the long-term ambulatory treatment of heart failure in patients with rheumatic heart lesions].
    Koshlia VI
    Ter Arkh; 1986; 58(11):51-5. PubMed ID: 3824191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Particular features of photolabile substances in tablets.
    Aman W; Thoma K
    Pharmazie; 2003 Sep; 58(9):645-50. PubMed ID: 14531462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The hemodynamic effectiveness of molsidomine infusions in patients with acute coronary insufficiency].
    Krüger R; Grewe R
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():26-9. PubMed ID: 7968897
    [No Abstract]   [Full Text] [Related]  

  • 9. [Long-term use of the peripheral vasodilator corvaton in the polyclinic stage of rehabilitation of patients with myocardial infarction and subclinical manifestations of circulatory insufficiency (clinico-hemodynamic study)].
    Petrov DV
    Ter Arkh; 1987; 59(4):108-12. PubMed ID: 3589985
    [No Abstract]   [Full Text] [Related]  

  • 10. Hemodynamic effects of SIN-1 in acute left heart failure.
    Ibrahim TM; Unger PH; Sobolski J; Depelchin P; Jottrand M; Degre S
    Cardiovasc Drugs Ther; 1989 Aug; 3(4):557-61. PubMed ID: 2488105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of treating stenocardia patients with obzidan, corvaton and corinfar based on the indices of spirometric bicycle ergometry and of central hemodynamics].
    Korabel'shchikova NI; Rishko NV; Bichko MV
    Vrach Delo; 1985 Aug; (8):19-21. PubMed ID: 3840931
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hemodynamics effects of continuous infusion of molsidomine and nitrates and subsequent oral medication in therapy of acute myocardial infarct].
    Honikel HJ; Fehske W
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():17-20. PubMed ID: 7968894
    [No Abstract]   [Full Text] [Related]  

  • 13. [Continuous molsidomine infusions in patients with unstable angina pectoris and acute myocardial infarct].
    Münzel T; Kasper W; Just H
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():30-3. PubMed ID: 7968898
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of corvaton on ischemic left-ventricular damage and hemodynamic indicators in patients with acute myocardial infarction].
    Khal'fen ESh; Shvarts IL; Zolotarev VA
    Kardiologiia; 1988 Oct; 28(10):101-2. PubMed ID: 3226037
    [No Abstract]   [Full Text] [Related]  

  • 15. [Coronary dilatation after intracoronary administration of SIN-1 and intravenous molsidomine administration].
    Hug J; Hasenfuss G; Wollschläger H; Just HJ; Bonzel T
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():34-7. PubMed ID: 7968899
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term clinical and hemodynamic results of the treatment of refractory cardiac failure with molsidomine].
    Kulas A; Escudier B; Hannachi N; Kolski H; Witchitz S; Acar J
    Arch Mal Coeur Vaiss; 1984 Jan; 77(1):92-9. PubMed ID: 6422898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of molsidomine once-a-day in patients with stable angina pectoris.
    Messin R; Opolski G; Fenyvesi T; Carreer-Bruhwyler F; Dubois C; Famaey JP; Géczy J
    Int J Cardiol; 2005 Jan; 98(1):79-89. PubMed ID: 15676171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative short-term effect of once-daily molsidomine on chronic angina in general practitioners' versus cardiologists' coronary patient populations.
    Messin R
    Adv Ther; 2014 Jan; 31(1):91-106. PubMed ID: 24307221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molsidomine and isosorbide dinitrate: a comparative trial of tolerance in long-term intake by IHD patients with stable angina of effort].
    Alimova EV; Martsevich SIu; Kutishenko NP; Metelitsa VI
    Ter Arkh; 1997; 69(12):37-40. PubMed ID: 9503532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The clinical efficacy of the first Russian angiotensin-converting enzyme inhibitor methiopril in patients with heart failure].
    Glezer MG; Orlova LL; Titova DKh; Shvarts GIa
    Klin Med (Mosk); 1995; 73(3):49-51. PubMed ID: 8577109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.